South African-born biotech entrepreneur Patrick Soon-Shiong has officially emerged as the wealthiest individual in Los Angeles, with an estimated net worth of $8.4 billion, according to recent billionaire rankings highlighted by Forbes and regional business publications.
Born in Port Elizabeth, now Gqeberha, Soon-Shiong built his fortune through a series of high-value biotechnology ventures and breakthrough medical innovations that transformed cancer treatment globally.
His rise to the top of Los Angeles’ wealth rankings underscores the growing influence of life sciences entrepreneurs within global billionaire circles, as healthcare innovation increasingly competes with technology and finance as a source of ultra-high-net-worth wealth creation.
The Capital Behind the Fortune
Soon-Shiong’s wealth was built primarily through the development and commercialisation of Abraxane, a pioneering cancer treatment used in breast, lung, and pancreatic cancer therapies. The success of the drug led to the sale of Abraxis BioScience to Celgene in a transaction valued at nearly $3 billion in 2010.
Since then, he has expanded his capital base through investments in biotechnology, artificial intelligence, media, telecommunications, semiconductor technologies, and sports.
His portfolio includes ownership of the Los Angeles Times, a minority stake in the Los Angeles Lakers, and control of healthcare and technology businesses under the NantWorks and ImmunityBio ecosystems.
Who Is Behind the Move
Unlike many billionaires who inherited wealth or built fortunes through traditional industries, Soon-Shiong represents a new class of scientific entrepreneurs whose wealth is rooted in intellectual property and healthcare innovation.
After graduating from the University of the Witwatersrand, he emigrated to North America, where he pursued a career in surgery and medical research before moving into biotechnology entrepreneurship.
Today, his family office deploys capital across multiple sectors with a focus on medical innovation, data infrastructure, advanced computing, and precision healthcare.
Why It Matters
Soon-Shiong’s position as Los Angeles’ richest resident reflects a broader shift in global wealth creation.
Biotechnology founders are increasingly joining the ranks of the world’s wealthiest individuals as demand accelerates for advanced healthcare solutions, personalised medicine, and artificial intelligence applications in medicine.
For South Africa, his success reinforces the country’s role as a source of globally competitive talent and entrepreneurial leadership.
South Africa remains Africa’s largest millionaire market, despite continued emigration among high-net-worth individuals. The rise of globally successful South African-born entrepreneurs highlights the international reach of the country’s human capital.
What It Signals for Global Wealth Positioning
Soon-Shiong’s ascent illustrates how billionaire capital is increasingly concentrated around intellectual property, scientific innovation, and healthcare infrastructure.
The next generation of billionaire wealth may be built less on natural resources and more on ownership of breakthrough technologies, patents, and data-driven healthcare platforms.
His growing influence across biotechnology, media, artificial intelligence, and sports demonstrates how modern family offices are diversifying beyond traditional asset classes to build interconnected ecosystems capable of generating long-term strategic value.
For investors and policymakers alike, the message is clear: the future of billionaire wealth will be shaped by those who control innovation at the intersection of healthcare and technology.
